China Resources takes control of AVIC's Aviation General Hospital

China Resources has moved to take control of AVIC's Aviation General Hospital through a 60-40 joint venture and a management contract, gaining a flagship tertiary hospital in Beijing.

The plan surfaced in a concentration-of-undertakings notice published by the State Administration for Market Regulation, which vets deals between large companies before they close. It marks one of the last big transfers of a hospital owned by an industrial state group.

How the deal is structured

China Resources Co., Ltd. and Aviation Industry Corporation of China (AVIC) will each put money into a new joint venture, holding 60% and 40% respectively. The JV will then take over day-to-day running of the hospital in Beiyuan, Beijing, under a long-term management contract, giving the two central state groups joint control.

China Resources Co., Ltd. was set up in December 1986, with Wang Xiangming as its legal representative, according to the corporate records database Tianyancha. Its registered capital is about 19.14 billion yuan (about $2.7 billion), and its approved business scope includes hospital investment and hospital management. Tianyancha lists it as the core holding vehicle of China Resources Group.

The structure — a joint venture, a 60-40 split and a management contract — avoids a direct transfer of ownership. Aviation General Hospital is a large public institution with a substantial payroll, unusual assets and a longstanding role in aviation medical support. A straightforward equity transfer would bring long approvals and personnel friction.

Under the JV, AVIC keeps a say over the hospital's history and its special medical support duties. China Resources, as controlling shareholder, takes charge of centralized procurement, budgets and clinical development.

Why the sale is happening now

SASAC, the state asset regulator, has drawn a hard line: state groups must shed businesses outside their main remit, including hospitals, through free transfers, trusteeship, joint ventures or restructuring led by specialist healthcare state groups.

Over the past few decades, groups such as AVIC, CNPC and State Grid built hundreds of staff hospitals and clinics across the country. Under the DRG/DIP payment reform, which pays hospitals by diagnosis and procedure, those hospitals have struggled to keep up on equipment upgrades, recruitment of senior doctors and cost control. They lack the cross-regional clinical networks and bulk purchasing power of specialist operators.

For AVIC, handing over the operating rights to its largest and most fully accredited tertiary hospital is a way to concentrate on aviation equipment, its core business.

A Beijing foothold for China Resources

China Resources Medical and China Resources Healthcare run and manage more than 100 medical institutions with over 10,000 beds across more than 10 provinces. Most sit in second- and third-tier cities and lower-tier counties in East, South and Central China.

The group has lacked a top-tier tertiary hospital in central Beijing, where medical resources and academic reputations are concentrated. Aviation General Hospital has more than 1,000 beds and millions of outpatient and emergency visits a year, with clinical strength in neurosurgery, cerebrovascular disease and obstetrics and gynecology.

China Resources intends to use the hospital as a national academic anchor and referral center for complex cases, linking it to senior academic teams and medical schools while supporting the group's regional hospitals. Its pharmaceutical distribution network could also fold the hospital's drug, high-value consumable and device purchasing into national bulk buying, cutting intermediary costs and improving cash flow.

What could go wrong

The first test is staff stability. Many doctors and nurses at the hospital come from the defense industrial system and value their existing posts and benefits. Rolling out strict corporate performance targets and tight cost control under zero-markup drug sales will test whether China Resources can raise efficiency without losing senior specialists.

The second is building distinctive disciplines under Beijing's tight insurance budgets and DRG reviews. Expanding beds or prescribing broadly no longer works. The two groups must show they can build durable advantages in aviation medicine and minimally invasive cerebrovascular treatment.

The filing sends a clear signal to the healthcare sector: the specialist restructuring of state-owned hospital assets is in its final, harder phase. The era of scattered staff hospitals is over, and large specialist medical groups are building national networks. Whether the joint venture turns Aviation General Hospital into a showcase for cross-industry state hospital restructuring is a question its managers will have to answer in the wards and operating rooms.